Objective: To evaluate the efficacy of exercise and intra-articular ozonized platelet rich plasma (IA-OPRP) injections as management for sever grad IV knee osteoarthritis (KOA). Methods: Over 18-month period (January 1, 2018– July 31, 2019), 33 patients (21 females and 12 males) with 58 grade IV osteoarthritic knees were retrospectively studied. Severity of KOA was assessed according to the clinical features and Kellgren &Lawrencegrading scale. All patients underwent 8-weeks simple exercises followed by 4 sessions of IA-OPRP.OPRP was prepared by centrifuging patients’ own blood and activated by passing 1 ml of ozone for each 1 ml of platelet rich plasma. A questionnaire was used to categorize the pain severity into mild, moderate, and severe and the response to therapy was graded as excellent, good, fair, and poor. Results: The mean age was 63.7 years. The top co-morbid condition were overweight and obesity (n=28, 84.8%) whereas diabetes and hypertension ranked second (n=15 each, 45.4%). All patients had severe pain of grad IV knee OA. Overall, exercise and four IA-OPRP injections yielded good-excellent results in (72.4%) of the treated joints (p˂0.01) with no significant sex-related difference in pain response (p>0.01). Conclusion: Exercise and IA-OPRP seems to be a safe, effective and cheap method for relieving the chronic pain of severeknee OA.
Objectives: The anterior cruciate ligament (ACL) is one of the most common injured knee ligaments and it is one of the most frequent injuries seen in orthopedic practice Methods: This is a retrospective study of 20 patients (14 female and 6 male) with ACL tear managed by intra articular activated PRP injection in the first author private clinic in Kirkuk over 2 years period (August 1, 2017–July 31, 2019). A detailed history was taken according to a questionnaire and a complete physical and radiological (MRI) examination was done. A sample of patient’s own blood was used to prepare PRP by a process of two repeated centrifugation. Longevity resources EXT50 Ozone Generator with oxygen tank and CGA870 Oxygen Regulator were used for activation of PRP. The clinical notes were reviewed to ascertain the clinical presentations and response of patients to PRP therapy. Results: The mean age was 55±10.38years. The age groups affected with ACL were 50-59 and 60-69 years (n: 7, 35%) for each, while (n:5,25%) from age group 40-49 years and (n: 1, 5%) was from age group 20-29. Although 19 patient (95%) have at least one co-morbid condition, all the patient (n:20, 100%) show good response.7 patient (35%) received three doses of PRP and 13 patient (65%) received four doses to get good response. Conclusion: Even though PRP and Ozone are not expensive therapies, they seem to be safe and effective in pain management of ACL tear.
هدفت الدراسة إلى لتقييم فعالية حقن الرباط الجانبي الأنسي بدلالة السونار بالبلازما الغنية بالصفائح الدموية كطريقة لمعالجة آلام الركبة. طريقة البحث: دراسة اعتيادية أجريت على مدى سنتين ونصف (1 كانون ثاني 2017 – 31 تموز 2019)، 31 مريضا (21 إناث و10 ذكور) راجعوا العيادة الخاصة للباحث الثالث الدكتور عبد الله أحمد محمد في محافظة كركوك، العراق بسبب شكواهم من آلام الركبة، تم حقن الرباط الجانبي الأنسي للركبة بدلالة السونار بالبلازما الغنية بالصفائح الدموية التي تم تحضيرها بواسطة الطرد المركزي للدم المسحوب من نفس المريض. الاستجابة للعلاج صنفت إلى ممتاز، جيد، مقبول وضعيف النتائج: معدل العمر كان 52 ± 1,5 سنة. معظم المرضى (عدد 27, 87%) تلقوا حقن لمرة واحدة، معظم المرضى (عدد 28, 90,3 %) أظهروا أما استجابة جيدة أو ممتازة للعلاج، بينما ثلاثة مرضى فقط (9.7%) أظهروا إما استجابة مقبولة أو ضعيفة وكان هناك فرق ذو دلالة إحصائية معنوية بين المجموعتين. الاستنتاج: حقن الرباط الجانبي الأنسي بالبلازما الغنية بالصفائح الدموية بدلالة السونار يبدو أنه طريقة فعالة، أمينة ورخيصة لمعالجة آلام الركبة الناتجة من التمزق الجزئي للرباط المذكور
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.